Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Dec 12;79(2):312–319. doi: 10.1093/jac/dkad379

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2023. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 3. — Pie charts of bacteraemic patients with E. coli isolates tested with two drugs [ceftriaxone (CRO) and levofloxacin (LVX)] categorized into four types according to the results of antimicrobial susceptibility to both drugs between (a) clinics (0–19 beds) and (b) outpatient settings in hospitals (≥20 beds) in 2018. The total number of bacteraemic E. coli patients with isolates tested with both drugs stratified by type of medical facility did not include those with isolates that were neither susceptible nor resistant to both drugs. The blue portion of the pie chart indicates the isolates that were susceptible to both CRO and LVX. The yellow portion represents isolates susceptible to CRO but resistant to LVX. The green portion indicates the isolates resistant to CRO but susceptible to LVX. The red portion represents isolates resistant to both CRO and LVX. The percentage of bacteraemic patients with each of the four types of E. coli isolates is shown in the pie chart along with the number of patients.